237 related articles for article (PubMed ID: 20538504)
1. Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis.
Desai RS; Mamatha GS; Khatri MJ; Shetty SJ
Oral Oncol; 2010 Jul; 46(7):553-8. PubMed ID: 20538504
[TBL] [Abstract][Full Text] [Related]
2. Cell death does not herald epithelial involution ("atrophy") in oral sub mucous fibrosis: a TEM study.
Rajendran R; Sunil ; Twinkle SP; Anikumar TV; Annie J
Indian J Dent Res; 2004; 15(1):13-9. PubMed ID: 15682790
[TBL] [Abstract][Full Text] [Related]
3. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study.
Pammar C; Nayak RS; Kotrashetti VS; Hosmani J
J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of HIF-1alpha in malignant transformation of oral submucous fibrosis.
Tilakaratne WM; Iqbal Z; Teh MT; Ariyawardana A; Pitiyage G; Cruchley A; Stewart JE; Hagi-Pavli E; Lalli A; Waseem A; Parkinson EK; Fortune F
J Oral Pathol Med; 2008 Jul; 37(6):372-7. PubMed ID: 18221327
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
6. Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis.
Jayasooriya PR; Nadeeka Jayasinghe KA; Mudiyanselage Tilakaratne W
J Investig Clin Dent; 2011 Aug; 2(3):171-5. PubMed ID: 25426787
[TBL] [Abstract][Full Text] [Related]
7. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis.
Zhou S; Qu X; Yu Z; Zhong L; Ruan M; Ma C; Wang M; Zhang C; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055
[TBL] [Abstract][Full Text] [Related]
8. Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization.
Lunde ML; Roman E; Warnakulasuriya S; Mehrotra R; Laranne J; Vasstrand EN; Ibrahim SO
Cancer Genomics Proteomics; 2014; 11(3):127-40. PubMed ID: 24969693
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
[TBL] [Abstract][Full Text] [Related]
10. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin expression in oral submucous fibrosis--an immunohistochemical study.
Ranganathan K; Kavitha R; Sawant SS; Vaidya MM
J Oral Pathol Med; 2006 Jan; 35(1):25-32. PubMed ID: 16393250
[TBL] [Abstract][Full Text] [Related]
12. Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes.
Anura A; Kazi A; Pal M; Paul RR; Sengupta S; Chatterjee J
Histochem Cell Biol; 2018 Jul; 150(1):61-75. PubMed ID: 29687243
[TBL] [Abstract][Full Text] [Related]
13. [Expression of S100 in oral submucose fibrosis].
Xie XL; Tang ZG; Yao ZG
Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):388-90. PubMed ID: 14653125
[TBL] [Abstract][Full Text] [Related]
14. [Expression of FHIT and MDM2 in oral submucous fibrosis and canceration tissues].
Yin X; Wen C; Han Y; Gao Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):572-5. PubMed ID: 20622329
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization.
Utsunomiya H; Tilakaratne WM; Oshiro K; Maruyama S; Suzuki M; Ida-Yonemochi H; Cheng J; Saku T
J Oral Pathol Med; 2005 Sep; 34(8):498-507. PubMed ID: 16091118
[TBL] [Abstract][Full Text] [Related]
16. Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study.
Thubashini M; Malathi N; Kannan L
Indian J Dent Res; 2011; 22(2):256-9. PubMed ID: 21891896
[TBL] [Abstract][Full Text] [Related]
17. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
[TBL] [Abstract][Full Text] [Related]
18. Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis.
Pal M; Chaudhuri SR; Jadav A; Banerjee S; Paul RR; Dutta PK; Ghosh B; Chatterjee J; Chaudhuri K
Tissue Cell; 2008 Dec; 40(6):425-35. PubMed ID: 18573513
[TBL] [Abstract][Full Text] [Related]
19. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
20. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression.
Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Sengupta S; Chatterjee J
J Clin Pathol; 2010 Oct; 63(10):894-9. PubMed ID: 20876321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
